These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10669940)

  • 21. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer-mediated immunocamouflage of red blood cells: effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells.
    Wang D; Kyluik DL; Murad KL; Toyofuku WM; Scott MD
    Sci China Life Sci; 2011 Jul; 54(7):589-98. PubMed ID: 21701803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood product transfusions and reactions.
    Osterman JL; Arora S
    Emerg Med Clin North Am; 2014 Aug; 32(3):727-38. PubMed ID: 25060259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report: immune anti-D stimulated by transfusion of fresh frozen plasma.
    Connolly M; Erber WN; Grey DE
    Immunohematology; 2005; 21(4):149-51. PubMed ID: 16472015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyethylene Glycol Camouflaged Earthworm Hemoglobin.
    Jani VP; Jelvani A; Moges S; Nacharaju P; Roche C; Dantsker D; Palmer A; Friedman JM; Cabrales P
    PLoS One; 2017; 12(1):e0170041. PubMed ID: 28099525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes.
    Bradley AJ; Scott MD
    Am J Hematol; 2007 Nov; 82(11):970-5. PubMed ID: 17654505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.
    Hendrickson JE; Tormey CA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):635-51. PubMed ID: 27113001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of immunization against erythrocyte antigens c, E and K caused by blood transfusion].
    Overbeeke MA; Dudok de Wit C
    Ned Tijdschr Geneeskd; 1994 May; 138(22):1116-8. PubMed ID: 8008124
    [No Abstract]   [Full Text] [Related]  

  • 30. The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching.
    Schonewille H; van Zijl AM; Wijermans PW
    Transfusion; 2003 Jul; 43(7):939-44. PubMed ID: 12823754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent binding of polyethylene glycol to the surface of red blood cells as detected and followed up by cell electrophoresis and rheological methods.
    Sabolovic D; Sestier C; Perrotin P; Guillet R; Tefit M; Boynard M
    Electrophoresis; 2000 Jan; 21(2):301-6. PubMed ID: 10675005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical camouflage of antigenic determinants: stealth erythrocytes.
    Scott MD; Murad KL; Koumpouras F; Talbot M; Eaton JW
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7566-71. PubMed ID: 9207132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method to optimize PEG-coating of red blood cells.
    Hashemi-Najafabadi S; Vasheghani-Farahani E; Shojaosadati SA; Rasaee MJ; Armstrong JK; Moin M; Pourpak Z
    Bioconjug Chem; 2006; 17(5):1288-93. PubMed ID: 16984140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding red blood cell alloimmunization triggers.
    Hendrickson JE; Tormey CA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):446-451. PubMed ID: 27913514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review.
    Havemann H; Lichtiger B
    Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs.
    Bradley AJ; Test ST; Murad KL; Mitsuyoshi J; Scott MD
    Transfusion; 2001 Oct; 41(10):1225-33. PubMed ID: 11606820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stealth erythrocytes--a possible transfusion product for the new century?
    Garratty G
    Vox Sang; 2000; 78 Suppl 2():143-7. PubMed ID: 10938944
    [No Abstract]   [Full Text] [Related]  

  • 38. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects.
    Everett ET; Kao KJ; Scornik JC
    Transplantation; 1987 Jul; 44(1):123-9. PubMed ID: 3603672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.